Zhiguang Zhou

24.4k total citations · 5 hit papers
465 papers, 15.2k citations indexed

About

Zhiguang Zhou is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Zhiguang Zhou has authored 465 papers receiving a total of 15.2k indexed citations (citations by other indexed papers that have themselves been cited), including 236 papers in Genetics, 215 papers in Endocrinology, Diabetes and Metabolism and 170 papers in Surgery. Recurrent topics in Zhiguang Zhou's work include Diabetes and associated disorders (226 papers), Pancreatic function and diabetes (154 papers) and Diabetes Management and Research (144 papers). Zhiguang Zhou is often cited by papers focused on Diabetes and associated disorders (226 papers), Pancreatic function and diabetes (154 papers) and Diabetes Management and Research (144 papers). Zhiguang Zhou collaborates with scholars based in China, United States and Canada. Zhiguang Zhou's co-authors include Gan Huang, Xia Li, Weiping Jia, Yufei Xiang, Jianping Weng, Aimin Xu, Linong Ji, Wenying Yang, Lin Yang and Juming Lu and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Zhiguang Zhou

452 papers receiving 15.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Diabetes among Men and Women in China

2010 2.5k citations Wenying Yang, Juming Lu et al. profile →
Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

2008 766 citations Zhiguang Zhou et al. profile →
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

2020 560 citations Zhiguang Zhou, Yufei Xiang et al. Journal of Autoimmunity profile →
The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1

2016 456 citations Zhiguang Zhou et al. profile →
Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0

2025 25 citations Xia Li, Zhiguang Zhou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhiguang Zhou China	55	5.7k	4.8k	3.8k	3.8k	2.2k	465	15.2k
Bernhard O. Boehm Germany	59	3.7k 0.6×	2.8k 0.6×	2.8k 0.7×	3.0k 0.8×	2.1k 1.0×	307	13.7k
Jill M. Norris United States	70	4.2k 0.7×	1.9k 0.4×	5.4k 1.4×	4.1k 1.1×	2.9k 1.3×	313	16.8k
François Pattou France	67	5.4k 1.0×	4.1k 0.9×	3.0k 0.8×	8.5k 2.2×	4.0k 1.8×	429	17.4k
Jianping Weng China	52	5.4k 1.0×	3.8k 0.8×	1.4k 0.4×	2.5k 0.7×	2.0k 0.9×	324	12.5k
Jerome I. Rotter United States	80	3.5k 0.6×	6.1k 1.3×	8.3k 2.2×	5.5k 1.5×	3.8k 1.7×	494	22.0k
Guang Ning China	63	4.9k 0.9×	5.4k 1.1×	2.1k 0.5×	2.7k 0.7×	3.0k 1.3×	546	16.0k
Jeffrey P. Krischer United States	74	6.0k 1.1×	2.6k 0.5×	8.3k 2.2×	7.1k 1.9×	1.4k 0.6×	353	17.8k
Paolo Pozzilli Italy	62	6.9k 1.2×	2.4k 0.5×	6.4k 1.7×	5.6k 1.5×	1.4k 0.6×	443	14.3k
Thomas R. Pieber Austria	76	9.6k 1.7×	3.9k 0.8×	3.2k 0.8×	5.3k 1.4×	1.4k 0.6×	489	20.3k
Marju Orho‐Melander Sweden	56	3.5k 0.6×	4.2k 0.9×	3.5k 0.9×	2.4k 0.6×	3.4k 1.5×	252	13.7k

Countries citing papers authored by Zhiguang Zhou

Since Specialization

Citations

This map shows the geographic impact of Zhiguang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiguang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiguang Zhou more than expected).

Fields of papers citing papers by Zhiguang Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiguang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiguang Zhou. The network helps show where Zhiguang Zhou may publish in the future.

Co-authorship network of co-authors of Zhiguang Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiguang Zhou. A scholar is included among the top collaborators of Zhiguang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiguang Zhou. Zhiguang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Xiajie, et al.. (2024). Predictors of and barriers to follow-up uptake: analysis of factors and perceived barriers among high-risk individuals with diabetes after screening in China. Public Health. 232. 128–131.

Zhong, Ting, Xinyu Li, Xinyu Li, et al.. (2024). CXCL12-CXCR4 mediates CD57+ CD8+ T cell responses in the progression of type 1 diabetes. Journal of Autoimmunity. 143. 103171–103171. 8 indexed citations

Li, Jiaqi, et al.. (2024). Effects of gut microbiome on type 1 diabetes susceptibility and complications: A large‐scale bidirectional Mendelian randomization and external validation study. Diabetes Obesity and Metabolism. 26(8). 3306–3317. 1 indexed citations

Shi, Xiajie, et al.. (2023). Effect of smartphone apps on glycemic control in young patients with type 1 diabetes: A meta-analysis. Frontiers in Public Health. 11. 1074946–1074946. 19 indexed citations

Zhang, Yu Shrike, Wan-Yu Wang, Qianrong Wang, et al.. (2023). ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression. Cell Reports. 42(6). 112654–112654. 12 indexed citations

Ding, Jin, Yan Chen, Zhiguo Xie, et al.. (2023). Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals. Journal of Diabetes Investigation. 15(1). 34–43. 3 indexed citations

Zou, Wenjing, Jiang Zhu, Jie Fan, et al.. (2023). Cognitive function and neuroimaging characteristics in patients with childhood‐onset type 1 diabetes mellitus. Diabetes/Metabolism Research and Reviews. 39(4). e3613–e3613. 2 indexed citations

Tang, Xiao‐Han, Xiang Yan, Gan Huang, et al.. (2022). Latent autoimmune diabetes in youth shows greater autoimmunity than latent autoimmune diabetes in adults: Evidence from a nationwide, multicenter, cross‐sectional study. Pediatric Diabetes. 23(5). 578–587. 7 indexed citations

Lin, Jian, Shuoming Luo, Gan Huang, et al.. (2022). The missing heritability in type 1 diabetes. Diabetes Obesity and Metabolism. 24(10). 1901–1911. 5 indexed citations

10.

Tan, Tingting, Yufei Xiang, Chao Deng, et al.. (2022). Variable frequencies of peripheral T-lymphocyte subsets in the diabetes spectrum from type 1 diabetes through latent autoimmune diabetes in adults (LADA) to type 2 diabetes. Frontiers in Immunology. 13. 974864–974864. 11 indexed citations

11.

Yang, Lin, Huiying Liang, Xinyuan Liu, et al.. (2021). Islet Function and Insulin Sensitivity in Latent Autoimmune Diabetes in Adults Taking Sitagliptin: A Randomized Trial. The Journal of Clinical Endocrinology & Metabolism. 106(4). 1529–1541. 15 indexed citations

12.

Li, Long, Hong Zhang, Jun Tang, et al.. (2021). Accurate diagnosis and heterogeneity analysis of a 17q12 deletion syndrome family with adulthood diabetes onset and complex clinical phenotypes. Endocrine. 73(1). 37–46. 8 indexed citations

13.

Zhu, Yaxi, Qian Liu, Zhiguang Zhou, & Yasuhiro Ikeda. (2017). PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration. Stem Cell Research & Therapy. 8(1). 240–240. 220 indexed citations

14.

Anderson, George W., Geneviève Deceuninck, Zhiguang Zhou, et al.. (2017). Hospitalisation for lower respiratory tract infection in children in the province of Quebec, Canada, before and during the pneumococcal conjugate vaccine era. Epidemiology and Infection. 145(13). 2770–2776. 7 indexed citations

15.

Tang, Jun, Chen-Yi Tang, Fang Wang, et al.. (2017). Genetic diagnosis and treatment of a Chinese ketosis-prone MODY 3 family with depression. Diabetology & Metabolic Syndrome. 9(1). 5–5. 6 indexed citations

16.

Zheng, Ying, Zhen Wang, Hongwei Shen, et al.. (2015). miR-101a and miR-30b contribute to inflammatory cytokine-mediated β-cell dysfunction. Laboratory Investigation. 95(12). 1387–1397. 61 indexed citations

17.

Ji, Linong, Puhong Zhang, Jianping Weng, et al.. (2015). Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China—Study Design and Baseline Characteristics. Diabetes Technology & Therapeutics. 17(10). 735–744. 33 indexed citations

18.

Hu, Ming, et al.. (2012). Effects of Frequency of Follow-Up on Quality of Life of Type 2 Diabetes Patients on Oral Hypoglycemics. Diabetes Technology & Therapeutics. 14(9). 777–782. 13 indexed citations

19.

Liu, Shiping, Hui Mo, Weili Tang, et al.. (2010). [The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes].. PubMed. 49(5). 405–9. 1 indexed citations

20.

Li, Xia, Xiang Yan, Gan Huang, et al.. (2009). Protective effects of 1‐α‐hydroxyvitamin D3 on residual β‐cell function in patients with adult‐onset latent autoimmune diabetes (LADA). Diabetes/Metabolism Research and Reviews. 25(5). 411–416. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact